Xconomy: Adimab News, Articles and Opinions

“adimab” Archives

Entry	Author	Date	Location
Bio Roundup: Rare Disease Showdowns, Prices on TV, Dealmania & More	Ben Fidler	05/10/19	National
The Winners of the 2017 Xconomy Awards Are…	Corie Lok	09/26/17	Boston
Going Big or Against the Tide: Meet the Big Idea & Contrarian Award Finalists	Corie Lok	09/14/17	Boston
Invenra Signs On With Merck in Antibody Discovery Partnership	Jeff Buchanan	07/28/17	Wisconsin
MIT’s Jacks Leans on Disney Family, Not VCs, to Hatch New Startup	Ben Fidler	08/11/16	Boston
Gerngross Mulls Buying Back GlycoFi After Merck Closes HQ	Ben Fidler	05/17/16	Boston
East Coast Biotech Roundup: Sarepta, Nico, Ironwood & More	Ben Fidler	04/28/16	Boston
Nimbus’s LLC Origins Pay off As Gilead Shells Out $400M For Liver Drug	Ben Fidler	04/04/16	Boston
East Coast Bio Roundup: PCSK9 Battle, NYU Startups, Blueprint & More	Ben Fidler	03/17/16	Boston
Racing Zika: For Every Short Cut, There’s An Open Question	Alex Lash	03/15/16	National
Stealth Co Unveiling, New Speakers Added to Nov. 17 Healthcare Event	Robert Buderi	11/13/15	Boston
Veterans Day Special Ending For Our Nov. 17 Health Summit: Save $75	Robert Buderi	11/09/15	Boston
Special Rate Ends Today For Our Nov. 17 Health Summit: Save $100	Editors	11/03/15	Boston
Alector Raises $32M For Immune-Based Neuro Drug Development	Alex Lash	09/16/15	San Francisco
East Coast Biotech Roundup: PrecisionFDA, Avitide, Foresight & More	Ben Fidler	08/07/15	Boston
Avitide Gets $7.6M More to Purify Complex Biologics	Ben Fidler	08/06/15	Boston
East Coast Biotech Roundup: NY Bio, Synageva, Kadmon & More	Ben Fidler	05/08/15	New York
With $43M, Nimbus Sheds “Discovery” Tag, Heads to First Clinical Test	Ben Fidler	03/18/15	Boston
NimbleGen Cofounder Opens Invenra, A “Cell-Free” Antibody Shop	Alex Lash	11/05/14	Wisconsin
East Coast Biotech Roundup: Gerngross, Akili, Intercept, & More	Ben Fidler	01/10/14	Boston
East Coast Biotech Roundup: Vertex, Dimension, Merrimack, & More	Ben Fidler	11/01/13	Boston
Alector Goes After Alzheimer’s, With Cash from Polaris & OrbiMed	Luke Timmerman	10/31/13	San Francisco
East Coast Life Sciences Roundup: Foundation, Ophthotech, Sato, & More	Ben Fidler	09/27/13	Boston
East Coast Life Sciences Roundup: Mana, Medivizor, Regado, & More	Ben Fidler	08/23/13	New York
Adimab Teams Up With Celgene, Innovent, in Latest Partnership Deals	Ben Fidler	08/20/13	Boston
East Coast Life Sciences Roundup: Sarepta, Agios, Gerngross, & (Much) More	Ben Fidler	07/26/13	Boston
Adimab Turns Cash Flow Positive With GSK, Biogen Tech Transfer Deals	Ben Fidler	07/26/13	Boston
Tillman Gerngross’ Plan to Revamp Tech Transfer at Dartmouth	Ben Fidler	07/24/13	Boston
East Coast Life Sciences Roundup: Optimer, Bind, Pfizer, and More	Bernadette Tansey	04/05/13	Boston
Gilead Sciences Building on HIV, Becoming Cancer Drug Force	Luke Timmerman	04/01/13	National
Page 1 of 4	next page »

Underwriters and Partners

Xpertise: Watch + Learn

Sponsored · Whitepaper
Monitoring Solutions for Pharma-CRO/CMO Partnerships to Maintain Quality & Timelines
Implementing electronic solutions for risk mitigation
XiltriX

Sponsored · Whitepaper
Protecting Valuable Life Science Assets & Equipment: Monitoring Solutions
Remain compliant and ensure optimal productivity
XiltriX

Xconomy Insight · Webinar
The New Era of Emerging Therapies Webinar Series
Potential cures and treatments for diseases are on the horizon for a growing number of patients, thanks to recent breakthroughs in CRISPR gene-editing technologies and in cell and gene therapy.